Skip to main content
Top
Published in:

Open Access 26-05-2024 | Community-Acquired Pneumonia | Case report

Community-acquired pneumonia associated with immunosuppression due to follicular thyroid cancer: a case report

Authors: Lilia Jannet Saldarriaga Sandoval, Modesta Alcántara Rojas, Fabiola Pinedo Idrogo

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

We present the case of a woman with cancer, which weakened the immune system and increased the risk of infection. Thus, infections are a frequent complication of cancer. The development of community-acquired pneumonia, an acute respiratory infectious disease that damages the lung parenchyma, caused by the invasion of pathogenic microorganisms, can lead to respiratory failure with multiorgan failure due to respiratory sepsis.

Case presentation

Case report of a 38-year-old mixed-race woman with diabetes mellitus and irregular treatment, who was admitted with community-acquired pneumonia complicated by type I respiratory failure requiring mechanical ventilation. During her hospital stay, she developed ventilator-associated pneumonia, recurrent empyema, bronchopleural fistula, refractory septic shock and multiorgan dysfunction despite multiple interventions. The patient required prolonged mechanical ventilation, vasopressor support and antibiotic therapy. After 62 days, metastatic papillary thyroid carcinoma was diagnosed. She presented with hypoparathyroidism and permanent hypocalcemia. She died after multiple complications and a refractory critical condition.

Conclusion

The case exemplifies the potential severity of community-acquired pneumonia in a patient with risk factors such as diabetes and immunosuppression. It highlights the complexity of treating multiple comorbidities and the importance of multidisciplinary management with close surveillance for timely interventions for complications.
Literature
3.
go back to reference Araiza-Sánchez JM, González-Noris PY, Espinoza Espinosa JJ, Robledo-Jaramillo CX. Manejo de la hipoxia durante ventilación unipulmonar en un paciente con absceso mediastinal y mediastinitis para toracotomía abierta. Reporte de caso. CASO CLÍNICO Respirar. 2023;15(2):128–33. https://doi.org/10.55720/respirar.15.2.6.CrossRef Araiza-Sánchez JM, González-Noris PY, Espinoza Espinosa JJ, Robledo-Jaramillo CX. Manejo de la hipoxia durante ventilación unipulmonar en un paciente con absceso mediastinal y mediastinitis para toracotomía abierta. Reporte de caso. CASO CLÍNICO Respirar. 2023;15(2):128–33. https://​doi.​org/​10.​55720/​respirar.​15.​2.​6.CrossRef
6.
go back to reference Gómez-Gómez B, Sánchez-Luna JP, Pérez-Beltrán CF, Díaz-Greene EJ, Rodríguez-Weber FL. Choque séptico. Lo que sabíamos y lo que debemos saber. Artículo de revisión Med Int Méx. 2017;33(3):381–91. Gómez-Gómez B, Sánchez-Luna JP, Pérez-Beltrán CF, Díaz-Greene EJ, Rodríguez-Weber FL. Choque séptico. Lo que sabíamos y lo que debemos saber. Artículo de revisión Med Int Méx. 2017;33(3):381–91.
7.
go back to reference Brands X, Haak BW, Klarenbeek AM, Otto NA, Faber DR, Lutter R, Scicluna BP, Wiersinga WJ, van der Poll T. Concurrent immune suppression and hyperinflammation in patients with community-acquired pneumonia. Front Immunol. 2020;6(11):796. https://doi.org/10.3389/fimmu.2020.00796. (Erratum in: Front Immunol. 2020;11:626667).CrossRef Brands X, Haak BW, Klarenbeek AM, Otto NA, Faber DR, Lutter R, Scicluna BP, Wiersinga WJ, van der Poll T. Concurrent immune suppression and hyperinflammation in patients with community-acquired pneumonia. Front Immunol. 2020;6(11):796. https://​doi.​org/​10.​3389/​fimmu.​2020.​00796. (Erratum in: Front Immunol. 2020;11:626667).CrossRef
11.
go back to reference Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Critical Care Med. 2017;45(3):486–552.CrossRef Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Critical Care Med. 2017;45(3):486–552.CrossRef
12.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2021;44(Supplement 1):S1–232. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2021;44(Supplement 1):S1–232.
14.
go back to reference World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention, and control. Geneva: World Health Organization; 2009. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention, and control. Geneva: World Health Organization; 2009.
Metadata
Title
Community-acquired pneumonia associated with immunosuppression due to follicular thyroid cancer: a case report
Authors
Lilia Jannet Saldarriaga Sandoval
Modesta Alcántara Rojas
Fabiola Pinedo Idrogo
Publication date
26-05-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04576-2

Other articles of this Issue 1/2024

Journal of Medical Case Reports 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare